Prostate Specific Antigen [PSA] & Prostate Cancer Diagnosis
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commonly used to diagnose prostate cancer.
Source: medindia.net
![Prostate Specific Antigen [PSA] & Prostate Cancer Diagnosis - Vimarsana News](https://images.medindia.net/patientinfo/950_400/causes-of-rise-in-psa-levels.jpg)
Benign Prostatic Hypertrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Benign Prostatic Hypertrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Benign Prostatic Hypertrophy Today - Breaking & Trending Today
Testosterone Supplements: Overcoming Current Misconceptions
About one fifth of patients with symptomatic testosterone deficiency receive treatment, partly because of misconceptions about the risks for therapy.
Source: medscape.com
Prostate Risks Similar for Testosterone Therapy and Placebo
For men with hypogonadism and low prostate cancer risk, TRT didn't increase the risk for prostate adverse events, said a new analysis likely to inform decision-making.
Source: medscape.com
Testosterone Replacement Therapy and Prostate Cancer Risk
A large randomized controlled trial found that testosterone replacement therapy did not increase the risk for prostate cancer in middle-aged and older men with hypogonadism.
Source: medscape.com
Drugs For Benign Prostatic Hypertrophy Market Report 2024 - Market to Reach $5.45 billion in 2028 - Opportunities in Minimally Invasive Treatments, Personalized Medicine and Combination Therapies
/PRNewswire/ -- The "Drugs For Benign Prostatic hypertrophy Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The drugs for...
Source: prnewswire.com